Healthtech companies combine blood testing analytics with an initial focus on improving America’s cardiovascular health.
Health optimization technology company Ultrahuman has partnered with health analytics platform InsideTracker to enhance cardiovascular health for US consumers. By leveraging insights from both platforms, the collaboration seeks to empower individuals with actionable data tailored to their unique physiology.
The partnership introduces Blood Vision, Ultrahuman’s blood-testing platform, to the United States for the first time. Rather than adhering to disease-centric benchmarks, Blood Vision is more longevity-focused, emphasizing proactive health and personalized wellness strategies, and creating individualized roadmaps for optimizing cardiovascular health, vitality and aging.
Known for delivering personalized recommendations to enhance longevity and performance, InsideTracker is integrating its Heart Category Test into the Blood Vision platform. The scientifically validated test evaluates critical cardiovascular biomarkers, such as lipid profiles, inflammatory markers and metabolic parameters, providing insights informed by the latest longevity research.
“Today’s health consumer is incredibly sophisticated, and those of us in the industry need to keep up,” said InsideTracker CEO Rony Sellam. “That’s what this partnership is all about.”
The collaboration also extends to Ultrahuman’s Ring AIR smart ring product and its Cardio Adaptability PowerPlug. The Ring AIR monitors sleep, resting heart rate, heart rate variability, movement and skin temperature, to produce data on physiological stress, recovery and overall health. The Cardio Adaptability PowerPlug, built on Ultrahuman’s data stack, provides insights into cardiovascular strain, autonomic balance and resilience.
By correlating biomarkers from the Ring AIR with blood data, the platform will deliver lifestyle recommendations, such as improving recovery through sleep optimization, reducing inflammation with dietary adjustments, or fine-tuning exercise routines based on HRV trends.
The partnership between the two companies is expected to expand in scope, with future plans to expand offerings to cover additional biomarker panels for metabolic health, immunity and hormonal balance.
Mohit Kumar, Founder and CEO of Ultrahuman, stressed the partnership’s emphasis on shifting focus from reactive to preventive health.
“This is especially important for ensuring America’s long-term health and wellness,” he said. “With personalized cardiovascular insights and lifestyle interventions, they will now have a view of their current and future health that’s not only comprehensive but also actionable.”
